Raymond James Financial Services Advisors Inc. boosted its holdings in CVS Health Corp (NYSE:CVS) by 32.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,218,359 shares of the pharmacy operator’s stock after buying an additional 301,775 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in CVS Health were worth $79,828,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of CVS. Bell Rock Capital LLC grew its stake in shares of CVS Health by 764.0% during the 4th quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 382 shares during the period. Daiwa SB Investments Ltd. bought a new stake in shares of CVS Health during the 4th quarter valued at about $30,000. Acima Private Wealth LLC bought a new stake in shares of CVS Health during the 4th quarter valued at about $33,000. Cornerstone Advisors Inc. grew its stake in shares of CVS Health by 71.6% during the 3rd quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock valued at $40,000 after purchasing an additional 212 shares during the period. Finally, Certified Advisory Corp grew its stake in shares of CVS Health by 46.3% during the 4th quarter. Certified Advisory Corp now owns 638 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 202 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

In other news, SVP James David Clark sold 1,664 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $58.14, for a total transaction of $96,744.96. Following the sale, the senior vice president now directly owns 8,557 shares of the company’s stock, valued at approximately $497,503.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director C David Brown II acquired 10,000 shares of the firm’s stock in a transaction dated Monday, March 11th. The shares were purchased at an average cost of $53.18 per share, for a total transaction of $531,800.00. Following the completion of the acquisition, the director now directly owns 16,222 shares in the company, valued at $862,685.96. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 23,600 shares of company stock worth $1,270,896 and have sold 412,039 shares worth $27,326,012. 0.53% of the stock is owned by corporate insiders.

A number of research firms have issued reports on CVS. Leerink Swann began coverage on CVS Health in a research note on Tuesday, December 11th. They set an “outperform” rating for the company. Goldman Sachs Group reissued a “neutral” rating and issued a $87.00 price target on shares of CVS Health in a report on Thursday, November 29th. Morgan Stanley set a $92.00 price target on CVS Health and gave the stock a “buy” rating in a report on Friday, February 22nd. Evercore ISI began coverage on CVS Health in a report on Wednesday, November 28th. They issued an “outperform” rating and a $89.00 price target on the stock. Finally, Loop Capital set a $80.00 price target on CVS Health and gave the stock a “hold” rating in a report on Wednesday, November 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $84.18.

NYSE CVS opened at $54.05 on Thursday. The company has a debt-to-equity ratio of 1.22, a quick ratio of 0.65 and a current ratio of 1.03. CVS Health Corp has a 12 month low of $51.93 and a 12 month high of $82.15. The company has a market capitalization of $71.85 billion, a P/E ratio of 7.63, a price-to-earnings-growth ratio of 1.08 and a beta of 0.95.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 EPS for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.07. The company had revenue of $54.42 billion for the quarter, compared to analysts’ expectations of $53.78 billion. CVS Health had a positive return on equity of 17.49% and a negative net margin of 0.31%. The firm’s revenue was up 12.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.92 EPS. As a group, equities analysts forecast that CVS Health Corp will post 6.8 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Tuesday, April 23rd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 22nd. This represents a $2.00 annualized dividend and a dividend yield of 3.70%. CVS Health’s dividend payout ratio (DPR) is 28.25%.

COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/cvs-health-corp-cvs-holdings-boosted-by-raymond-james-financial-services-advisors-inc/2923818.html.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: How can investors find ex-dividend dates?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.